Case-control study of laparoscopic versus abdominal myomectomy

Area of Science:

• Minimally Invasive Surgery
• Gynecologic Surgery
• Uterine Fibroid Treatment

Background:

• Uterine fibroids are common, often requiring surgical intervention.
• Myomectomy is the surgical removal of fibroids, preserving the uterus.
• Surgical approaches include traditional abdominal and minimally invasive laparoscopic methods.

Purpose of the Study:

• To compare the outcomes of laparoscopic myomectomy versus abdominal myomectomy.
• To evaluate differences in recovery, operative time, and blood loss between the two surgical approaches.

Main Methods:

• A case-control study design was employed, frequency-matching patients based on fibroid weight.
• The study included 25 patients undergoing laparoscopic or laparoscopically-assisted myomectomy (lap) and 51 patients undergoing abdominal myomectomy (abd).
• Statistical analysis utilized t-tests, Wilcoxon rank-sum tests, chi-square tests, and analysis of covariance.

Main Results:

• Laparoscopic myomectomy patients experienced significantly shorter hospital stays (30.5 vs. 65.0 hours) and reduced postoperative narcotic use (14.8 vs. 24.0 hours).
• Operative time was longer for the laparoscopic group (222.5 vs. 180.0 minutes), but estimated blood loss was comparable between groups.
• Fibroid weights were similar between the laparoscopic and abdominal groups after matching (151 g vs. 170.0 g).

Conclusions:

• Laparoscopic myomectomy is a safe and viable alternative to abdominal myomectomy for treating uterine fibroids.
• Patients undergoing laparoscopic myomectomy benefit from quicker recovery and less reliance on postoperative pain medication.
• The choice of laparoscopic approach does not result in increased intraoperative blood loss compared to the abdominal route.